DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Nordic Bioscience, an international biotech organization, to offer clinical trial logistics services in Hong Kong.
HONG KONG, Dec. 12, 2013 /PRNewswire/ -- DKSH's Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, has signed an agreement with Nordic Bioscience to provide clinical trial logistics services in Hong Kong. Under the agreement, DKSH is responsible for the importation of investigational products, products storage, delivery, return and destruction.
"Hong Kong has excellent infrastructure in terms of transportation, workforce and legal framework for conducting clinical trials. What we need is to find a partner which can offer clinical trial logistics services in a safe manner with high security and reliability," said Jeppe Ragnar Andersen, Head of Clinical Development, Nordic Bioscience. "We are happy to work with DKSH Hong Kong. Its specialized clinical trial team should help us ensure that the logistics of our trials are managed with the expertise and quality we demand."
"Our company is certified to comply with international standards (ISO, GMP, GDP), ensuring our clients peace of mind on storage and service execution. Our distribution center environment together with our talented team offer the best possible solution for clinical trial logistics services in Hong Kong," said Richard Holloway, Vice President, DKSH Healthcare, Hong Kong. "The number of clinical trials in Asia has been increasing steadily. We are seeing rising demands and referrals from clinical research organizations on clinical trial logistics services in Hong Kong. This value-added service poised great business potential in addition to our traditional offerings."
The new partnership will further strengthen DKSH's market position in healthcare in Hong Kong while contributing incrementally to the Group's overall profitability over time.
